市场调查报告书
商品编码
1541702
2024-2032 年按产品(仪器、耗材、配件)、应用(临床研究、诊断、法医等)和地区分類的高效液相层析 (HPLC) 市场报告High-Performance Liquid Chromatography (HPLC) Market Report by Product (Instruments, Consumables, Accessories), Application (Clinical Research, Diagnostics, Forensic, and Others), and Region 2024-2032 |
2023 年,全球高效能液相层析 (HPLC) 市场规模达到 56 亿美元。 展望未来, IMARC Group预计到 2032 年,市场规模将达到 82 亿美元,2024 年复合年增长率 (CAGR) 为 4.1%。 .
高效液相层析(HPLC)是指从混合物中分离不同化合物的层析技术。该技术使用玻璃储液器来容纳溶液,使用多个泵来输送含有样品混合物的加压液体溶剂,使用固体吸附材料填充的色谱柱、萤光、质谱、紫外线 (UV) 光谱和电化学检测器和资料收集系统。它通常用于分析化学和生物化学,以识别、量化和纯化各个成分。因此,该技术广泛应用于微量分析、疾病临床诊断、食品品质控制和药物开发。
全球製药业的显着成长是创造积极市场前景的关键因素之一。 HPLC 广泛用于分析药物样品、品质控制、製造复杂的药物并获得更快、更准确的化合物分离结果。此外,对用于纯化单株抗体的可靠 HPLC 系统的需求不断增长也推动了市场的成长。柱和泵浦技术的各种进步以及小型化、自动化和电脑化 HPLC 设备的开发是其他成长诱导因素。这些进步有助于进行高品质的分析,在更短的时间内提供更准确的结果,并增强使用者的整体便利性。 HPLC 仪器製造商也正在开发创新的色谱柱设计,能够承受较小的表面多孔颗粒的高压,这是另一个主要的生长诱导因素。生物样本库的新兴趋势以及生命科学领域广泛的研发(R&D)活动是预计进一步推动市场发展的其他因素。
The global high-performance liquid chromatography (HPLC) market size reached US$ 5.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032.
High-performance liquid chromatography (HPLC) refers to the chromatographic technique of separating different compounds from a mixture. The technique uses a glass reservoir to hold the solution, numerous pumps to pass the pressurized liquid solvent containing the sample mixture, a column filled with a solid adsorbent material, fluorescence, mass-spectrometric, ultraviolet (UV)-spectroscopic and electrochemical detectors and data collection systems. It is commonly used for analytical chemistry and biochemistry to identify, quantify and purify individual components. As a result, the technique finds extensive applications for trace analysis, clinical diagnosis of diseases, quality control in food products and pharmaceutical drug development.
Significant growth in the pharmaceutical industry across the globe represents one of the key factors creating a positive outlook for the market. HPLC is widely used to analyze drug samples, quality control, manufacturing complex pharmaceutical drugs and obtaining faster and accurate compound separation results. Furthermore, the increasing demand for reliable HPLC systems for the purification of monoclonal antibodies is also driving the market growth. Various advancements in the column and pump technologies and the development of miniaturized, automated and computerized HPLC devices are acting as other growth-inducing factors. These advancements have assisted in conducting high-quality analysis that provides more accurate results in lesser time and enhances the overall convenience for the user. HPLC instrument manufacturers are also developing innovative column designs that can withstand high pressure from smaller, superficially porous particles, which is acting as another major growth-inducing factor. The emerging trend of biobanking and extensive research and development (R&D) activities in the field of life sciences are some of the other factors that are anticipated to drive the market further.
IMARC Group provides an analysis of the key trends in each segment of the global high-performance liquid chromatography (HPLC) market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product and application.
Instruments
HPLC System
Automated
Manual
Detectors
Pumps
Others
Consumables
Columns
Tubes
Vials
Filters
Others
Accessories
Clinical Research
Diagnostics
Forensic
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Gilson Inc., Hitachi Ltd., Perkinelmer Inc., Phenomenex Inc. (Danaher Corporation), Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Corporation and Waters Corporation.